張生格+馮運(yùn)紅+葉安
【摘要】 目的 分析不同糖皮質(zhì)激素在膽道閉鎖患兒術(shù)后應(yīng)用的治療效果。方法 選取40例膽道閉鎖患兒, 按隨機(jī)數(shù)字表分成試驗(yàn)組和對(duì)照組, 各20例。兩組術(shù)后均給予糖皮質(zhì)激素, 試驗(yàn)組使用甲基強(qiáng)的松龍, 對(duì)照組使用地塞米松。對(duì)比兩組術(shù)后1個(gè)月膽管炎發(fā)生率、總膽紅素水平、直接膽紅素水平。結(jié)果 所有入選對(duì)象均較好的完成了術(shù)后治療, 無(wú)死亡及中途退出病例。試驗(yàn)組患兒的膽管炎發(fā)生率40.00%明顯低于對(duì)照組的75.00%, 差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)。試驗(yàn)組患兒術(shù)后1個(gè)月總膽紅素水平為(137.61±42.17)μmol/L, 直接膽紅素水平為(76.57±26.99)μmol/L, 均顯著低于對(duì)照組的(164.34±40.08)μmol/L、(95.83±25.14)μmol/L, 差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)。結(jié)論 甲基強(qiáng)的松龍?jiān)谀懙篱]鎖患兒術(shù)后對(duì)預(yù)防膽管炎的發(fā)生及降低血膽紅素的治療效果比地塞米松好。
【關(guān)鍵詞】 甲基強(qiáng)的松龍;地塞米松;膽道閉鎖;膽管炎
DOI:10.14163/j.cnki.11-5547/r.2017.22.006
【Abstract】 Objective To analyze the treatment effect of different glucocorticoids in the treatment of biliary atresia in children. Methods A total of 40 biliary atresia children were divided by random number table method into experimental group and control group, with 20 cases in each group. Both groups received glucocorticoids after treatment, and the experimental group was treated with methylprednisolone, and the control group was treated with dexamethasone. Comparison were made on incidence of cholangitis, total bilirubin and direct bilirubin level in 1 month after operation in two groups. Results All patients completed the postoperative treatment without death or withdrawal. The experimental group had obviously lower incidence of cholangitis as 40.00% than 75.00% in the control group, and the difference had statistical significance (P<0.05). The experimental group had total bilirubin level as (137.61±42.17) μmol/L and direct bilirubin level as (76.57±26.99) μmol/L in 1 month after operation, which were all significantly lower than (164.34±40.08) μmol/L and (95.83±25.14) μmol/L in the control group. Their difference had statistical significance (P<0.05). Conclusion Methylprednisolone shows better treatment effect in prevention of cholangitis and reduction of serum bilirubin for biliary atresia children.
【Key words】 Methylprednisolone; Dexamethasone; Biliary atresia; Cholangitis
膽道閉鎖是嬰兒梗阻性黃疸的常見(jiàn)原因[1], 其中以KasaiⅢ型膽道閉鎖最為常見(jiàn)。肝門(mén)空腸吻合術(shù)是目前治療該病的主要手段, 術(shù)后肝纖維化繼續(xù)發(fā)展及膽管炎都給膽道閉鎖的治療造成一定的影響, 常需輔助糖皮質(zhì)激素等藥物治療。本研究選取2011年1月~2016年12月的在本院手術(shù)治療的40例膽道閉鎖患兒, 分別在術(shù)后選擇甲基強(qiáng)的松龍和地塞米松進(jìn)行治療, 評(píng)價(jià)不同糖皮質(zhì)激素的治療方案對(duì)膽道閉鎖肝門(mén)空腸吻合術(shù)后膽管炎發(fā)生率及膽紅素變化的影響, 旨在選出治療效果較好的方案, 以改善膽道閉鎖患兒的預(yù)后。
1 資料與方法
1. 1 一般資料 選取2011年1月~2016年12月在本院手術(shù)治療的40例膽道閉鎖患兒, 按隨機(jī)數(shù)字表分成試驗(yàn)組和對(duì)照組, 各20例。試驗(yàn)組中男9例, 女11例;年齡23~96 d, 平均年齡(62.69±13.36)d;術(shù)前血清總膽紅素水平130~283 μmol/L, 平均血清總膽紅素水平(172.43±61.47)μmol/L;直接膽紅素水平75~191 μmol/L, 平均直接膽紅素水平(102.55±36.73)μmol/L。
對(duì)照組中男8例, 女12例;年齡20~103 d, 平均年齡(61.73±12.88)d;術(shù)前血清總膽紅素水平125~280 μmol/L, 平均血清總膽紅素水平(170.36±60.48)μmol/L;直接膽紅素水平77~215 μmol/L, 平均直接膽紅素水平(105.42±39.06)μmol/L。所有患兒均以梗阻性黃疸、大便呈陶土色為臨床表現(xiàn), 經(jīng)手術(shù)確診。兩組患兒術(shù)前在年齡、性別、膽紅素等方面差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05), 具有可比性。